Rheumatoid Arthritis (RA) Clinical Research Study
Are you, or someone you know, living with Rheumatoid Arthritis?
Local research rheumatologists at the Cincinnati Rheumatic Disease Study Group (CRDSG) are recruiting participants to enroll in a clinical research study of an investigational drug, olokizumab, being tested in difficult to treat subgroups of Rheumatoid Arthritis (RA) patients. CRDSG is an organization of specialists dedicated to improving the care of patient with arthritis since 1991.
If you or a loved one are over 18 years old, have joints that are swollen and hurting, and other drugs and treatments you are currently taking are not working adequately, you may qualify for this clinical study.
You may qualify for this clinical study, if you meet the following criteria:
- You are 18 years old or older with a diagnosis of Rheumatoid Arthritis
- Are currently being treated with Methotrexate
- You have sore, swollen joints and you have received Methotrexate or a biologic drug as treatment, but have not experienced adequate relief of your symptoms
Study-related medication and study-related care is provided at no cost to qualified participants. Compensation may be given for travel.
Subjects who complete the first phase of the study will be eligible to participate in a longer term study in which treatment with the study medication is guaranteed.